MarketBeat has listed Alaunos Therapeutics, a US-based oncology company, as a penny stock.
1 report, 1 independent
Updated 00:00
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat has listed Alaunos Therapeutics, a US-based oncology company, as a penny stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Alaunos Therapeutics
immuno-oncology company
Nothing else this week.
-
MarketBeat
American personal finance blog